Use of octreotide for the treatment of protein‐losing enteropathy in dogs: Retrospective study of 18 cases

Abstract Background More than 50% of dogs with protein‐losing enteropathy (PLE) fail to respond to standard therapies. Octreotide, a somatostatin analogue, is used in cases of intestinal lymphangiectasia (IL) in humans with some success. Objectives Describe the use of octreotide in dogs with PLE inc...

Full description

Bibliographic Details
Main Authors: Sara A. Jablonski, Allison S. W. Mazepa, M. Katherine Tolbert
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.16966